CONDENSED CONSOLIDATED INTERIM STATEMENT OF LOSS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
EXPENSES
Accretion expense	$ 28,963	$ 28,963	$ 57,926	$ 57,926
Consulting	172,686	141,233	278,256	270,746
Directors' fees	20,000	20,000	40,000	40,000
Filing and regulatory	24,782	9,626	33,332	16,156
Foreign exchange loss	24,522	25,439	65,480	32,338
General and administrative	37,914	107,901	118,797	214,624
Geological, mineral, and prospect costs	113,618	204,035	237,607	258,559
Interest expense	112,363	91,125	210,178	123,248
Professional fees	70,033	113,124	224,129	236,824
Promotion and shareholder communication	77,371	51,044	85,319	58,407
Salaries	33,750	33,750	67,500	67,500
Loss	(716,002)	(826,240)	(1,418,524)	(1,376,328)
Gain (loss) on fair value adjustment on derivative liability	(746,509)	(272,421)	(728,525)	64,672
Other income	1,033	14,212	1,033	14,907
Net loss and comprehensive loss for the year	$ (1,461,478)	$ (1,084,449)	$ (2,146,016)	$ (1,296,749)
Basic loss per common share	$ (0.02)	$ (0.03)	$ (0.04)	$ (0.05)
Diluted loss per common share	$ (0.02)	$ (0.03)	$ (0.04)	$ (0.05)
Weighted average number of common shares outstanding (basic)	32,837,257	32,787,798	32,837,257	26,868,410
Weighted average number of common shares outstanding (diluted)	32,837,257	32,787,798	32,837,257	26,868,410